v3.25.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Total revenues $ 5,007 $ 4,839 $ 9,784 $ 9,489
Gross profit 1,985 2,002 3,997 3,904
Selling, general, and administrative 1,029 1,067 2,069 2,105
Research and development 302 327 646 651
Total operating expenses 1,331 1,395 2,714 2,756
Operating income 654 608 1,283 1,148
Interest and other financial charges – net 113 131 224 254
Non-operating benefit (income) costs (73) (101) (148) (204)
Other (income) expense – net 1 (1) (98) 8
Income before income taxes 613 578 1,304 1,090
Benefit (provision) for income taxes (113) (143) (216) (267)
Net income 500 435 1,088 823
Net (income) loss attributable to noncontrolling interests (14) (7) (39) (21)
Net income attributable to GE HealthCare $ 486 $ 428 $ 1,049 $ 802
Earnings per share attributable to GE HealthCare:        
Basic (in dollars per share) $ 1.06 $ 0.94 $ 2.30 $ 1.76
Diluted (in dollars per share) $ 1.06 $ 0.93 $ 2.29 $ 1.75
Weighted-average number of shares outstanding:        
Basic (in shares) 457 457 457 456
Diluted (in shares) 458 459 459 459
Product        
Total revenues $ 3,263 $ 3,207 $ 6,380 $ 6,253
Cost of sales 2,160 2,045 4,122 4,012
Service        
Total revenues 1,743 1,632 3,404 3,237
Cost of sales $ 863 $ 792 $ 1,665 $ 1,574